RDNTRadNet, Inc.
RadNet, Inc. (RDNT) provides diagnostic imaging and laboratory services, leveraging AI to enhance its offerings. The next catalyst is Sep 21, 2026 — Why RadNet (RDNT) Stock Is Down Today . Scouter has modeled bull and bear paths into this event, though no specific price targets are provided. Past catalysts are scored in The Read.
- Public fact: RadNet’s revenue grew 11.5% YoY to $2.22B in Q2 2026 .
- Scouter has modeled bull and bear paths into the next catalyst.
- Past catalysts are scored in The Read.
The schedule
- Mon9Nov
- Mon23Nov
RSNA 2026 AI Portfolio & Clinical Data Update
- Tue15Dec
2027 Medicare Physician Fee Schedule (MPFS) Digest
- Tue9Feb
- Tue11May
- Mon9Aug
Past
- Sun9Aug
Actual outcome: Bull · $73.81 at outcome
The company reported in-line EPS of -0.43, matching expectations, and provided positive forward guidance signaling stabilization in demand. The strategic developments, including the rebrand and Microsoft designations, reinforced long-term growth prospects, driving the stock toward the bull target despite the flat earnings report.
Quarterly earnings report covering Q2 2026 top-line imaging volumes and early margin updates on recent M&A.
- Thu25Jun
Actual outcome: Bull · $77.04 at outcome
RadNet's wholly owned digital health subsidiary, DeepHealth, received two FDA 510(k) clearances for its AI-powered Breast Suite. The clearances enable new capabilities including Breast Arterial Calcification assessment for cardiovascular risk and automated prior exam integration, boosting enthusiasm for RadNet's AI informatics business. [Market retrospective · Short-Term (6–10 days)] Missed anticipation: +30.2% from 2026-06-17 to 2026-07-28 (~3.4σ vs typical 10d vol). Target date 2026-07-03 reached; move through 2026-07-28 observed. Confidence 92%. [Market retrospective · Short-Term (6–10 days)] Updated observation 2026-07-29: +30.2% from 2026-06-17 (~3.4σ). Target date 2026-07-03 reached; move through 2026-07-29 observed. [Market retrospective · Short-Term (6–10 days)] Updated observation 2026-07-31: +30.2% from 2026-06-17 (~3.4σ). Target date 2026-07-03 reached; move through 2026-07-31 observed. [Market retrospective · Short-Term (6–10 days)] Updated observation 2026-08-03: +30.2% from 2026-06-17 (~3.4σ). Target date 2026-07-03 reached; move through 2026-08-03 observed. [Market retrospective · Short-Term (6–10 days)] Updated observation 2026-08-04: +30.2% from 2026-06-17 (~3.4σ). Target date 2026-07-03 reached; move through 2026-08-04 observed. [Market retrospective · Short-Term (6–10 days)] Updated observation 2026-08-05: +30.2% from 2026-06-17 (~3.4σ). Target date 2026-07-03 reached; move through 2026-08-05 observed. [Market retrospective · Short-Term (6–10 days)] Updated observation 2026-08-06: +30.2% from 2026-06-17 (~3.4σ). Target date 2026-07-03 reached; move through 2026-08-06 observed. [Market retrospective · Short-Term (6–10 days)] Updated observation 2026-08-06: +30.2% from 2026-06-17 (~3.4σ). Target date 2026-07-03 reached; move through 2026-08-06 observed. [Market retrospective · Short-Term (6–10 days)] Updated observation 2026-08-06: +30.2% from 2026-06-17 (~3.4σ). Target date 2026-07-03 reached; move through 2026-08-06 observed. [Market retrospective · Short-Term (6–10 days)] Updated observation 2026-08-06: +30.2% from 2026-06-17 (~3.4σ). Target date 2026-07-03 reached; move through 2026-08-06 observed. [Market retrospective · Short-Term (6–10 days)] Updated observation 2026-08-06: +30.2% from 2026-06-17 (~3.4σ). Target date 2026-07-03 reached; move through 2026-08-06 observed. [Market retrospective · Short-Term (6–10 days)] Updated observation 2026-08-07: +30.2% from 2026-06-17 (~3.4σ). Target date 2026-07-03 reached; move through 2026-08-07 observed. [Market retrospective · Short-Term (6–10 days)] Updated observation 2026-08-07: +30.2% from 2026-06-17 (~3.4σ). Target date 2026-07-03 reached; move through 2026-08-07 observed. [Market retrospective · Short-Term (6–10 days)] Updated observation 2026-08-07: +30.2% from 2026-06-17 (~3.4σ). Target date 2026-07-03 reached; move through 2026-08-07 observed. [Market retrospective · Short-Term (6–10 days)] Updated observation 2026-08-07: +30.2% from 2026-06-17 (~3.4σ). Target date 2026-07-03 reached; move through 2026-08-07 observed. [Market retrospective · Short-Term (6–10 days)] Updated observation 2026-08-07: +30.2% from 2026-06-17 (~3.4σ). Target date 2026-07-03 reached; move through 2026-08-07 observed. [Market retrospective · Short-Term (6–10 days)] Updated observation 2026-08-12: +30.2% from 2026-06-17 (~3.4σ). Target date 2026-07-03 reached; move through 2026-08-12 observed. [Market retrospective · Short-Term (6–10 days)] Updated observation 2026-08-13: +30.2% from 2026-06-17 (~3.4σ). Target date 2026-07-03 reached; move through 2026-08-13 observed. [Market retrospective · Short-Term (6–10 days)] Updated observation 2026-08-14: +30.2% from 2026-06-17 (~3.4σ). Target date 2026-07-03 reached; move through 2026-08-14 observed. [Market retrospective · Short-Term (6–10 days)] Updated observation 2026-08-17: +30.2% from 2026-06-17 (~3.4σ). Target date 2026-07-03 reached; move through 2026-08-17 observed. [Market retrospective · Short-Term (6–10 days)] Updated observation 2026-08-18: +30.2% from 2026-06-17 (~3.4σ). Target date 2026-07-03 reached; move through 2026-08-18 observed. [Market retrospective · Short-Term (6–10 days)] Updated observation 2026-08-20: +30.2% from 2026-06-17 (~3.4σ). Target date 2026-07-03 reached; move through 2026-08-20 observed.
RadNet's wholly owned digital health subsidiary, DeepHealth, received two FDA 510(k) clearances for its AI-powered Breast Suite. The clearances enable new capabilities including Breast Arterial Calcification assessment for cardiovascular risk and automated prior exam integration, boosting enthusiasm for RadNet's AI informatics business. [Market retrospective · Short-Term (6–10 days)] Missed anticipation: +30.2% from 2026-06-17 to 2026-07-28 (~3.4σ vs typical 10d vol). Target date 2026-07-03 reached; move through 2026-07-28 observed. Confidence 92%. [Market retrospective · Short-Term (6–10 days)] Updated observation 2026-07-29: +30.2% from 2026-06-17 (~3.4σ). Target date 2026-07-03 reached; move through 2026-07-29 observed. [Market retrospective · Short-Term (6–10 days)] Updated observation 2026-07-31: +30.2% from 2026-06-17 (~3.4σ). Target date 2026-07-03 reached; move through 2026-07-31 observed. [Market retrospective · Short-Term (6–10 days)] Updated observation 2026-08-03: +30.2% from 2026-06-17 (~3.4σ). Target date 2026-07-03 reached; move through 2026-08-03 observed. [Market retrospective · Short-Term (6–10 days)] Updated observation 2026-08-04: +30.2% from 2026-06-17 (~3.4σ). Target date 2026-07-03 reached; move through 2026-08-04 observed. [Market retrospective · Short-Term (6–10 days)] Updated observation 2026-08-05: +30.2% from 2026-06-17 (~3.4σ). Target date 2026-07-03 reached; move through 2026-08-05 observed. [Market retrospective · Short-Term (6–10 days)] Updated observation 2026-08-06: +30.2% from 2026-06-17 (~3.4σ). Target date 2026-07-03 reached; move through 2026-08-06 observed. [Market retrospective · Short-Term (6–10 days)] Updated observation 2026-08-06: +30.2% from 2026-06-17 (~3.4σ). Target date 2026-07-03 reached; move through 2026-08-06 observed. [Market retrospective · Short-Term (6–10 days)] Updated observation 2026-08-06: +30.2% from 2026-06-17 (~3.4σ). Target date 2026-07-03 reached; move through 2026-08-06 observed. [Market retrospective · Short-Term (6–10 days)] Updated observation 2026-08-06: +30.2% from 2026-06-17 (~3.4σ). Target date 2026-07-03 reached; move through 2026-08-06 observed. [Market retrospective · Short-Term (6–10 days)] Updated observation 2026-08-06: +30.2% from 2026-06-17 (~3.4σ). Target date 2026-07-03 reached; move through 2026-08-06 observed. [Market retrospective · Short-Term (6–10 days)] Updated observation 2026-08-07: +30.2% from 2026-06-17 (~3.4σ). Target date 2026-07-03 reached; move through 2026-08-07 observed. [Market retrospective · Short-Term (6–10 days)] Updated observation 2026-08-07: +30.2% from 2026-06-17 (~3.4σ). Target date 2026-07-03 reached; move through 2026-08-07 observed. [Market retrospective · Short-Term (6–10 days)] Updated observation 2026-08-07: +30.2% from 2026-06-17 (~3.4σ). Target date 2026-07-03 reached; move through 2026-08-07 observed. [Market retrospective · Short-Term (6–10 days)] Updated observation 2026-08-07: +30.2% from 2026-06-17 (~3.4σ). Target date 2026-07-03 reached; move through 2026-08-07 observed. [Market retrospective · Short-Term (6–10 days)] Updated observation 2026-08-07: +30.2% from 2026-06-17 (~3.4σ). Target date 2026-07-03 reached; move through 2026-08-07 observed. [Market retrospective · Short-Term (6–10 days)] Updated observation 2026-08-12: +30.2% from 2026-06-17 (~3.4σ). Target date 2026-07-03 reached; move through 2026-08-12 observed. [Market retrospective · Short-Term (6–10 days)] Updated observation 2026-08-13: +30.2% from 2026-06-17 (~3.4σ). Target date 2026-07-03 reached; move through 2026-08-13 observed. [Market retrospective · Short-Term (6–10 days)] Updated observation 2026-08-14: +30.2% from 2026-06-17 (~3.4σ). Target date 2026-07-03 reached; move through 2026-08-14 observed. [Market retrospective · Short-Term (6–10 days)] Updated observation 2026-08-17: +30.2% from 2026-06-17 (~3.4σ). Target date 2026-07-03 reached; move through 2026-08-17 observed. [Market retrospective · Short-Term (6–10 days)] Updated observation 2026-08-18: +30.2% from 2026-06-17 (~3.4σ). Target date 2026-07-03 reached; move through 2026-08-18 observed. [Market retrospective · Short-Term (6–10 days)] Updated observation 2026-08-20: +30.2% from 2026-06-17 (~3.4σ). Target date 2026-07-03 reached; move through 2026-08-20 observed.
- Mon2Mar
Actual outcome: Bear · $71.33 at outcome
RadNet delivered a strong Q4 2025 report, beating EPS estimates ($0.23 vs. $0.19) and posting record revenue, while also announcing the strategic AI acquisition of Gleamer SAS. Despite these positive fundamentals and an initial surge in shares, the stock ultimately fell 5.2% by the outcome date as investors took profits in a 'sell-the-news' pullback.